Disclosure Quest - Search SEC Filings

Name	Type of Offering	Accepted Date
Palvella Therapeutics, Inc. See All Filings	D	2022-12-30 15:53:45 UTC
Amount To Be Raised $37,704,498 Associated Brokers / Dealers N/A CIK Number 0001742961 Filed Document 0001878646-22-000061 Exclusions or Exemptions 506b Accepted Date 2022-12-30 15:53:45 UTC Type of Offering D Industry Biotechnology Principal Place of Business PENNSYLVANIA Revenue or Assets Decline to Disclose Type of Security Equity
Palvella Therapeutics, Inc. See All Filings	D	2020-06-03 11:40:20 UTC
Amount To Be Raised $45,000,002 Associated Brokers / Dealers N/A CIK Number 0001742961 Filed Document 0001742961-20-000002 Exclusions or Exemptions 506b Accepted Date 2020-06-03 11:40:20 UTC Type of Offering D Industry Biotechnology Principal Place of Business PENNSYLVANIA Revenue or Assets Decline to Disclose Type of Security Equity
Palvella Therapeutics, Inc. See All Filings	D/A	2019-08-12 15:37:52 UTC
Amount To Be Raised $5,000,000 Associated Brokers / Dealers N/A CIK Number 0001742961 Filed Document 0001192482-19-000333 Exclusions or Exemptions 506b Accepted Date 2019-08-12 15:37:52 UTC Type of Offering D/A Industry Biotechnology Principal Place of Business PENNSYLVANIA Revenue or Assets Decline to Disclose Type of Security Equity
Palvella Therapeutics, Inc. See All Filings	D	2019-04-11 17:41:33 UTC
Amount To Be Raised $4,000,000 Associated Brokers / Dealers N/A CIK Number 0001742961 Filed Document 0001742961-19-000001 Exclusions or Exemptions 506b Accepted Date 2019-04-11 17:41:33 UTC Type of Offering D Industry Biotechnology Principal Place of Business PENNSYLVANIA Revenue or Assets Decline to Disclose Type of Security Equity
Palvella Therapeutics, Inc. See All Filings	D	2018-06-14 10:27:26 UTC
Amount To Be Raised $5,000,000 Associated Brokers / Dealers N/A CIK Number 0001742961 Filed Document 0001742961-18-000001 Exclusions or Exemptions 506b Accepted Date 2018-06-14 10:27:26 UTC Type of Offering D Industry Biotechnology Principal Place of Business PENNSYLVANIA Revenue or Assets Decline to Disclose Type of Security Equity